Anthropic’s new Claude Science platform is gaining attention after the company revealed ambitions to go beyond providing AI tools and begin developing its own drugs, initially targeting neglected diseases. The platform combines literature review, coding, data analysis… https://t.co/cJbc7c2Zfx
Full content is available at the original source.
x.com
// related articles
Twitter/X: @elder_plinius @LYSIOS The timing makes the contrast hard to miss: Anthropic is IPO-ing at $70–78…
Twitter/X: @JakeDSBD24 @Kevin_Logan @bot People that had ultra like my self down graded to the $30 to keep t…
Twitter/X: Just tried the free version of Claude to create a SaaS launch video, and the results are CRAZY. …